Tano, Yulanda R.
HRN: 19-07-06 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/26/2024
03/26/2024
IV
900mg
Single Dose
S/P Completion Curettage
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes